Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Appointed director
CC transcript
Inv. presentation
Acq. announced
Appointed CFO
Innoviva, Inc. (INVA) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/28/2022 8-K/A Quarterly results
05/04/2022 8-K/A Quarterly results
07/21/2017 8-K/A Form 8-K/A - Current report: [Amend]
04/28/2017 8-K/A Form 8-K/A - Current report [Amend]
03/06/2014 8-K/A Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Master Agreement by and among Theravance, Inc., Theravance Biopharma, Inc. and Glaxo Group Limited",
"Collaboration Agreement Amendment by and between Theravance, Inc. and Glaxo Group Limited",
"Strategic Alliance Agreement Amendment by and between Theravance, Inc. and Glaxo Group Limited"
12/02/2011 8-K/A Form 8-K/A - Current report [Amend]
12/17/2010 8-K/A Form 8-K/A - Current report [Amend]
06/08/2010 8-K/A Form 8-K/A - Current report [Amend]
02/01/2008 8-K/A Form 8-K/A - Current report [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy